2271269-01-1
2271269-01-1 structure
- Name: UBX1325
- Chemical Name: UBX1325
- CAS Number: 2271269-01-1
- Molecular Formula: C53H59ClF3N6O10PS3
- Molecular Weight: 1159.69
- Catalog: Signaling Pathways Apoptosis Apoptosis
- Create Date: 2022-11-21 18:12:38
- Modify Date: 2025-08-25 13:50:36
-
UBX1325 is an Bcl-xL inhibitor that promotes apoptosis in senescent cells. UBX1325 is a potent anti-aging agent that can be used in studies of age-related eye diseases such as diabetic macular oedema (DME), age-related macular degeneration (AMD) and diabetic retinopathy (DR)[1].
| Name | UBX1325 |
|---|
| Description | UBX1325 is an Bcl-xL inhibitor that promotes apoptosis in senescent cells. UBX1325 is a potent anti-aging agent that can be used in studies of age-related eye diseases such as diabetic macular oedema (DME), age-related macular degeneration (AMD) and diabetic retinopathy (DR)[1]. |
|---|---|
| Related Catalog | |
| In Vitro | UBX1325 leads to a decrease in the anti-apoptotic Bcl-xL:Bim complex in retina by intravitreal (IVT) injection administration in oxygen induced retinopathy (OIR) C57BL/6 mice model[1]. UBX1325 can cause a decrease in retinal vascular permeability and promote retinal neovascularization in streptozotocin (STZ)-induced retinopathy mice model[1]. |
| References |
| Molecular Formula | C53H59ClF3N6O10PS3 |
|---|---|
| Molecular Weight | 1159.69 |